Advertisement

Infektionen durch Chromobacterium, Serratia, Erwinia und Flavobacterium (sog. Chromobakteriosen)

  • U. Berger
  • A.-M. Fahr
  • H. Einecke
Conference paper
  • 15 Downloads
Part of the Ergebnisse der Inneren Medizin und Kinderheilkunde / Advances in Internal Medicine and Pediatrics book series (KINDERHEILK. NF, volume 41)

Zusammenfassung

Pigmentbildende gramnegative Stäbchenbakterien haben in den letzten Jahren als gefährliche Infektionserreger zunehmend klinische Bedeutung erlangt. Die wichtigsten Keime dieser Gruppe sind in der Reihenfolge ihrer Häufigkeit: Serratia marcescens, Erwinia herbicola, Flavobacterium spp. und Chromobacterium violaceum.

This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

Chromobacterium

  1. 1.
    Beer, R.J.S., Jennings, B.E., Robertson, A.: The chemistry of bacteria. Part III. An indolylpyrrylmethene from violacein. J. chem. Soc. III, 2679 (1954)Google Scholar
  2. 2.
    Black, M.E., Shahan, J.: Bacillus violaceus infection in a human being. J. Amer. med. Ass. 110, 1270 (1938)Google Scholar
  3. 3.
    Broudin, L.: (1922) zit. nach Sneath, P.H.A. (1960)Google Scholar
  4. 4.
    Darrasse, H., Mazaud, R., Giudicelli, P., Camain, R.: Un cas humain mortel d’infection à Chromobacterium violaceum (septicémie et multiples abcès hépatiques). Bull. Soc. Path. exot. 48, 704 (1955)PubMedGoogle Scholar
  5. 5.
    Dhar, S.K., Johnson, R.: The oxidase activity of Chromobacterium. J. clin. Path. 26, 304 (1973)PubMedGoogle Scholar
  6. 6.
    Dauphinais, R.M.: Letter to the editor. Amer. J. clin. Path. 52, 230 (1969)Google Scholar
  7. 7.
    Dauphinais, R.M., Robben, G.G.: Fatal infection due to Chromobacterium violaceum. Amer. J. clin. Path. 50, 592 (1968)Google Scholar
  8. 8.
    Eltinge, E.T.: Status of the genus Chromobacterium. Int. Bull. Bact. Nomencl. Taxon. 7, 37 (1957)Google Scholar
  9. 9.
    Farrar, W.E., O’Dell, N.M.: β-Lactamase activity in Chromobacterium violaceum. J. infect. Dis. 134, 290 (1976)PubMedGoogle Scholar
  10. 10.
    Floch, H., Lajudie, P.: (1943) zit. nach Sneath, P.H.A. (1960)Google Scholar
  11. 11.
    Groves, M.G., Strauss, J.M., Abbas, J., Davis, CE.: Natural infections of gibbons with a bacterium producing violet pigment. J. infect. Dis. 120, 605 (1969)PubMedGoogle Scholar
  12. 12.
    Johnson, D.O., Pullian, J.D., Tanticharoenyos, P.: Chromobacterium septicemia in the gibbon. J. infect. Dis. 122, 563 (1970)Google Scholar
  13. 13.
    Johnson, W.M., Disalvo, A.F., Stuer, R.R.: Fatal Chromobacterium violaceum septicemia. Amer. J. clin. Path. 56, 400 (1971)Google Scholar
  14. 14.
    Laws, L., Hall, W.T.R.: (1964) zit. nach Groves, M.G. et al. (1969)Google Scholar
  15. 15.
    Leifson, E.: Morphological and physiological characteristics of the genus Chromobacterium. J. Bact. 71, 393 (1956)PubMedGoogle Scholar
  16. 16.
    Lesslar, J.E.: (1927) zit. nach Sneath, P.H.A. et al. (1953)Google Scholar
  17. 17.
    Martin, P.H.: (1927) zit. nach Sneath, P.H.A. (1960)Google Scholar
  18. 18.
    Möse, J.R., Pötsch, A.: Über biologische und bacteriostatische Eigenschaften des Prodigiosins und Violaceins. Arch. Hyg. 138, 52 (1954)Google Scholar
  19. 19.
    Nunnally, R.M., Dunlop, W.H.: Fatal septicemia due to Chromobacterium janthinum. J. La med. Soc. 120, 278 (1968)Google Scholar
  20. 20.
    Nunnally, R.M.: Letter to the editor. Amer. J. clin. Path. 52, 230 (1969)Google Scholar
  21. 21.
    Ognibene, A.J., Thomas, E.: Fatal infection due to Chromobacterium violaceum in Vietnam. Amer. J. clin. Path. 54, 607 (1970)Google Scholar
  22. 22.
    Schattenberg, H.J.: Experimental studies upon B. violaceus, isolated from a fulminating fatal human infection. Proc. Soc. exp. Biol. Med. (N.Y.) 45, 829 (1940)Google Scholar
  23. 23.
    Schattenberg, H.J., Harris, W.H.: A definite and unique occurrence of rapidly fatal infection caused by Bacillus violaceus manilae. J. Amer. med. Ass. 117, 2069 (1941)Google Scholar
  24. 24.
    Schattenberg, H.J., Harris, W.H.: Chromobacterium violaceum, var. manilae as a pathogenic microorganism J. Bact. 44, 509 (1942)PubMedGoogle Scholar
  25. 25.
    Sippel, W.L., Medina, G., Atwood, M.D.: Outbreaks of disease in animals associated with Chromobacterium violaceum. I. The disease in swine. J. Amer. vet. med. Ass. 124, 467 (1954)Google Scholar
  26. 26.
    Sivendra, R., Lo, H.S., Lim, K.T.: Identification of Chromobacterium violaceum: Pigmented and non-pigmented strains. J. gen. Microbiol. 90, 21 (1975)PubMedGoogle Scholar
  27. 27.
    Sivendra, R., Lo, H.S., Lim, K.T.: Letter to the editor. Amer. J. clin. Path. 64, 421 (1975)Google Scholar
  28. 27a.
    Sivendra, R., Tan, S.H.: Pathogenicity of nonpigmented cultures of Chromobacterium violaceum. J. clin. Microbiol. 5, 514 (1977)PubMedGoogle Scholar
  29. 28.
    Sneath, P.H.A.: Cultural and biochemical characteristics of the genus Chromobacterium. J. gen. Microbiol. 15, 70 (1956)PubMedGoogle Scholar
  30. 29.
    Sneath, P.H.A.: The change from polar to peritrichous flagellation in Chromobacterium sp. J. gen. Microbiol. 15, 99 (1956)PubMedGoogle Scholar
  31. 30.
    Sneath, P.H.A.: Conservation of the generic name Chromobacterium and designation of type species and type strains. Int. Bull. Bac. Nomencl. Taxon. 6, 65 (1956)Google Scholar
  32. 31.
    Sneath, P.H.A.: A study of the bacterial genus Chromobacterium. Iowa St. J. Sci. 34, 243 (1960)Google Scholar
  33. 32.
    Sneath, P.H.A., Buckland, F.E.: The serology and pathogenicity of the genus Chromobacterium. J. gen. Microbiol. 20, 414 (1959)PubMedGoogle Scholar
  34. 33.
    Sneath, P.H.A., Whelan, J.P.F., Singh, R.B., Edwards, D.: Fatal infection by Chromobacterium violaceum. Lancet 1953 II, 276Google Scholar
  35. 34.
    Snowe, R.J.: Chromobacterium violaceum: Pathogenic for man. J. infect. Dis. 123, 226 (1971)PubMedGoogle Scholar
  36. 35.
    Soule, M.H., Arbor, A.: A study of two strains of B. violaceus isolated from human beings. Amer. J. Path. 15, 592 (1939)Google Scholar
  37. 36.
    Victoria, B., Baer, H., Ayoub, E.M.: Successful treatment of systemic Chromobacterium violaceum infection. J. Amer. med. Ass. 230, 578 (1974)Google Scholar
  38. 37.
    Wijewanta, E.A., de S. Wettimuny, S.G.: Chromobacterium violaceum infection in pigs. Res. Vet. Sci. 10, 389 (1969)PubMedGoogle Scholar
  39. 38.
    Woolley, P.G.: Bacillus violaceus manilae. Johns Hopkins Hosp. Bull. 16, 89 (1905)Google Scholar
  40. 39.
    Wrede, F., Rothhaas, A.: Über das Violacein, den violetten Farbstoff des Bacillus violaceus I. Z. physiol. Chem. 223, 113 (1934).Google Scholar

Serratia

  1. 40.
    Aitoff, M., Dion, M., Dobkevitch, H.: Bacillus prodigiosus pathogène pour les animaux; endotoxine et réaction de Shwartzman. C.R. Soc. Biol. 123, 375 (1936)Google Scholar
  2. 41.
    Altemeier, W.A.: Clinical aspects in surgical patients. Antibiot. Chemother. 21, 184 (1976)PubMedGoogle Scholar
  3. 42.
    Anderhub, B., Pitt, T.L., Erdman, Y.J., Willcox, W.R.: A comparison of typing methods for Serratia marcescens. J. Hyg. 79, 89 (1977)Google Scholar
  4. 43.
    Angus, T.A.: Symposium on microbial insecticides. I. Bacterial pathogens of insects as microbial insecticides. Bact. Rev. 29, 364 (1965)PubMedGoogle Scholar
  5. 44.
    Aronson, J.D., Alderman, I.: The occurrence and bacteriological characteristics of S. marcescens from a case of meningitis. J. Bact. 46, 261 (1943)PubMedGoogle Scholar
  6. 45.
    Ashby, M.E.: Serratia osteomyelitis in heroin users. J. Bone Jt Surg. 58A, 132 (1976)Google Scholar
  7. 46.
    Atlas, E., Belding, M.: Serratia marcescens arthritis requiring amputation. J. Amer. med. Ass. 204, 167 (1968)Google Scholar
  8. 47.
    Ball, A.P., McGhie, D., Geddes, A.M.: Quart. J. Med. 46, 63 (1977)PubMedGoogle Scholar
  9. 47a.
    Ball, A.P., McGhie, D., Geddes, A.M.. Anonym: Lancet 1977 I, 636Google Scholar
  10. 48.
    Baquero, F., Carvajal, A., De Rafael, L., Reig, M., Salesa, R.: Etiology and epidemiology of neonatal septicemia in hospital units. Antibiot. Chemother. 21, 138 (1976)PubMedGoogle Scholar
  11. 49.
    Bastin, R., Frottier, J., Vilde, J.L., Lapresle, C.: Les endocardites bactériennes. Les enseignements d’une étude de 276 observations. Lyon méd. 225, 61 (1971)PubMedGoogle Scholar
  12. 50.
    Baumann, W., Emmrich, P.: Sepsis und andere Infektionen durch Serratia marcescens im Neugeborenen- und Säuglingsalter. Dtsch. med. Wschr. 99, 1755 (1974)PubMedGoogle Scholar
  13. 51.
    Berger, U.: Mikrobiologie der Mundhöhle, 1. Aufl. Berlin, München: Urban & Schwarzenberg 1955Google Scholar
  14. 52.
    Bertarelli, E.: Untersuchungen und Beobachtungen über die Biologie und Pathogenität des Bacillus prodigiosus. Zbl. Bakt. I. Abt. Orig. 34, 193, 312 (1903)Google Scholar
  15. 53.
    Bigger, J.F., Meltzer, G., Mandell, A., Bürde, R.M.: Serratia marcescens endophthalmitis. Amer. J. Ophthalm. 72, 1102 (1971)Google Scholar
  16. 54.
    du Bois Saint-Sévrin: Panaris des pêcheurs et microbe rouge de la sardine. Ann. Inst. Pasteur 8, 152 (1894)Google Scholar
  17. 55.
    Botzenhart, K., Kufferath, R.: Über die Vermehrung verschiedener Enterobacteriaceae sowie Pseudomonas aeruginosa und Alcaligenes spec, in destilliertem Wasser, entionisiertem Wasser, Leitungswasser und Mineralsalzlösung. Zbl. Bakt. Hyg., I. Abt. Orig. B 163, 470 (1976)Google Scholar
  18. 56.
    Bövre, K., Tönjum, A.M.: Non-pigmented Serratia marcescens var. kielensis as a probable cause of bronchopneumonia. Acta path, micro biol. scand. 58, 251 (1963)Google Scholar
  19. 57.
    Browaeys, J., Kwantes, M.: Diagnostic bactériologique des Serratia (A propos de deux cas). Ann. biol. clin. 20, 353 (1962)Google Scholar
  20. 58.
    Bund (Bern): Harmlos oder gefährlich? Bakterien-Experimente in amerikanischen Städten. Vom 24.12.1976Google Scholar
  21. 59.
    Burger, G.: Serratia marcescens Bizio 1823. Zbl. Bakt., I. Abt. Ref. 207, 97 (1967)Google Scholar
  22. 60.
    Burket, L.W., Burn, CG.: Bacteremias following dental extraction. Demonstration of source of bacteria by means of a non-pathogen (Serratia marcescens). J. dent. Res. 16, 521 (1937)Google Scholar
  23. 61.
    Cabrera, H.A.: An outbreak of Serratia marcescens, and its control. Arch, intern. Med. 123, 650 (1969)Google Scholar
  24. 62.
    Cardos, S.F., Florman, A.L., Simerkoff, M.S., Lanier, L.: Serratia marcescens: use of detailed characterization of strains to evaluate an increase of isolates in an intensive care unit. Amer. J. med. Sci. 266, 447 (1973)PubMedGoogle Scholar
  25. 63.
    Caselitz, F.-H.: Panoramawechsel in der Bakteriologie. Pathogenität bestimmter Mikroorganismen: Aeromonas hydrophila, Pseudomonas aeruginosa, Serratia marcescens. Mat. Med. (Nordmark) 23, 185 (1971)Google Scholar
  26. 64.
    Clayton, E., von Graevenitz, A.: Nonpigmented Serratia marcescens. J. Amer. med. Ass. 197, 1059 (1966)Google Scholar
  27. 65.
    Cooksey, R.C., Bannister, E.R., Farrar, W.E.: Antibiotic resistance patterns of clinical isolates of Serratia marcescens. Antimicrob. Agents Chemother. 7, 396 (1975)PubMedGoogle Scholar
  28. 66.
    Cooksey, R.C., Thorne, G.M., Farrar, W.E.: R factor mediated antibiotic resistance in Serratia marcescens. Antimicrob. Agents Chemother. 10, 123 (1976)PubMedGoogle Scholar
  29. 67.
    Council on Pharmacy and Chemistry: Erysipelas and prodigiosus toxins (Coley). J. Amer. med. Ass. 103, 1067 (1934)Google Scholar
  30. 68.
    Curtin, M.: Otorrhée chronique due au „Bacillus prodigiosus”. Ann. Oto-laryng. (Paris) 68, 738 (1951)Google Scholar
  31. 69.
    Daily Telegraph, London: vom 23.12.1976, zit. nach Severn, M.: Lancet 1977 I, 750Google Scholar
  32. 70.
    Daschner, F., Senska-Euringer, C.: Kontaminierte Infusionen als Ursache nosokomialer Serratia-marcescens-Sepsis bei Kindern. Dtsch. med. Wschr. 100, 2324 (1975)PubMedGoogle Scholar
  33. 71.
    Davis, J.T., Foltz, E., Blakemore, W.S.: Serratia marcescens. A pathogen of increasing clinical importance. J. Amer. med. Ass. 214, 2190 (1970)Google Scholar
  34. 72.
    Denney, J.D., Kaye, D., Hagstrom, J.W.C: Endocarditis due to Serratia marcescens. New Engl. J. Med. 276, 1362 (1967)Google Scholar
  35. 73.
    Déom, J., Mortelmans, J.: Etude d’une souche pathogène de Serratia marcescens. Rev. Immunol. 17, 394 (1953)Google Scholar
  36. 74.
    Derian, P.S., Fisher, L.C., Adkins, J.: Acute osteomyelitis from Serratia marcescens. Amer. J. Orthoped. 8, 96 (1966)Google Scholar
  37. 75.
    Dodson, W.H.: Serratia marcescens septicemia. Arch, intern. Med. 121, 145 (1968)Google Scholar
  38. 76.
    Donovan, T.L., Chapman, M.W., Harrington, K.D., Nagel, D.A.: Serratia arthritis. Report of seven cases. J. Bone Jt Surg. 58 A, 1009 (1976)Google Scholar
  39. 77.
    Duma, R.J., Warner, J.F., Dalton, H.P.: Septicemia from intravenous infusions. New Engl. J. Med. 284, 257 (1971)PubMedGoogle Scholar
  40. 78.
    Edwards, P.R., Ewing, W.H.: Identification of Enterobacteriaceae, 3. ed. Minneapolis: Burgess Publishing 1972Google Scholar
  41. 78a.
    Eickhoff, T.C., Ehret, J.M.: In vitro comparison of cefoxitin, cefamandole, cephalexin, and cephalotin. Antimicrob. Agents Chemother. 9, 994 (1976)PubMedGoogle Scholar
  42. 79.
    Elston, H.R., Magnuson, C.W.: Lung abscess caused by non-chromogenic Serratia marcescens. Amer. Rev. resp. Dis. 92, 624 (1965)PubMedGoogle Scholar
  43. 80.
    Epstein, E., Carson, T.E.: Serratia granuloma. J. Amer. med. Ass. 223, 670 (1973)Google Scholar
  44. 81.
    Ewing, W.H.: Differentiation of Enterobacteriaceae by biochemical reactions. Atlanta: DHEW Publ. No. (CDC) 74–8270 1973Google Scholar
  45. 82.
    Ewing, W.H., Davis, B.R., Reavis, R.W.: Studies on the Serratia group. Atlanta: CDC Lab. Manual 1959Google Scholar
  46. 83.
    Ewing, W.H., Johnson, J.G., Davis, B.R.: The occurrence of Serratia marcescens in nosocomial infections. Atlanta 1962Google Scholar
  47. 84.
    Farhoudi, H.O., Banks, T., Ali, N.: A case report of Serratia endocarditis with review of the literature. Med. Ann. D.C. 43, 401 (1974)Google Scholar
  48. 85.
    Farmer, J.J.: Epidemiological differentiation of Serratia marcescens: Typing by bacteriocin production. Appl. Microbiol. 23, 218 (1972)PubMedGoogle Scholar
  49. 86.
    Farmer, J.J., Davis, B.R., Hickman, F.W., Presley, D.B., Bodey, G.P., Negut, M., Bobo, R.A.: Detection of Serratia outbreaks in hospital. Lancet 1976 II, 455Google Scholar
  50. 87.
    Farmer, J.J., Silva, F., Williams, D.R.: Isolation of Serratia marcescens on deoxyribonuclease-toluidine blue-cephalotin agar. Appl. Microbiol. 25, 151 (1973)PubMedGoogle Scholar
  51. 88.
    Farrar, W.E., O’Dell, N.M.:β-Lactamases and resistance to penicillins and cephalosporins in Serratia marcescens. J. infect. Dis. 134, 245 (1976)PubMedGoogle Scholar
  52. 89.
    Fields, B.N., Uwaydah, M.M., Kunz, L.J., Swartz, M.N.: The so-called “paracolon” bacteria. Amer. J. Med. 42, 89 (1967)PubMedGoogle Scholar
  53. 90.
    Fischer, H., Ljashko: Wundbehandlung mit Bacterium prodigiosum (russisch). Chirurgia 5, 33 (1948)Google Scholar
  54. 90a. Fischer, H., Ljashko: Wundbehandlung mit Bacterium prodigiosum (russisch). Zbl. Bakt., I. Abt. Ref. 147, 313 (1950)Google Scholar
  55. 91.
    Fleming, P.C., Goldner, M., Glass, D.G.: Observations on the nature, distribution, and significance of cephalosporinase. Lancet 1963 I, 1399Google Scholar
  56. 92.
    Frédéricq, P., Gratia, A.: Sur la coagulation du plasma oxalaté par les cultures de B. prodigiosus. C.R. Soc. Biol. 140, 1131 (1946)Google Scholar
  57. 93.
    Freitag, V., Caselitz, F.-H.: Antikörpernachweis bei Serratia marcescens-Infektionen. Infection 3, 74 (1975)PubMedGoogle Scholar
  58. 94.
    Freitag, V., Morr-Strathmann, U., Caselitz, F.-H., Lawin, P.: Zur Bedeutung von Serratia marcescens-Infektionen auf Intensivstationen. Prakt. Anästh. 10, 119 (1975)Google Scholar
  59. 95.
    Fritsche, D., Dostal, C., Spieckermann, C.: Die Untersuchung des epidemiologischen Verhaltens von Serratia marcescens mit Hilfe der Bacteriocin-Typisierung. Zbl. Bakt. Hyg., I. Abt. Orig. 223 A, 513 (1973)Google Scholar
  60. 96.
    Fritsche, D., Spieckermann, C., Dostal, C.: Ökologisches Verhalten der Klebsielleae. Med. Klin. 67, 1246 (1972)PubMedGoogle Scholar
  61. 97.
    Fuller, A.T., Horton, J.M.: Marcescin, an antibiotic substance from Serratia marcescens. J. gen. Microbiol. 4, 417 (1950)PubMedGoogle Scholar
  62. 98.
    Gale, D., Lord, J.D.: Overgrowth of Serratia marcescens in respiratory tract, simulating hemoptysis. J. Amer. med. Ass. 164, 1328 (1957)Google Scholar
  63. 99.
    Gale, D., Sonnenwirth, A.C.: Frequent human isolation of Serratia marcescens. Arch, intern. Med. 109, 414 (1962)Google Scholar
  64. 100.
    Gaßner, A., Kleinberger, G., Pall, H., Pichler, M., Spitzy, K.H.: Serratia marcescens-Infektionen an einer internistischen Intensivstation. Vortr. 8. Tgg. Dtsch. Öst. Ges. Intern. Intensivmedizin, München 11.11.1976Google Scholar
  65. 101.
    Gaughran, E.R.L.: From superstition to science: The history of a bacterium. Trans. N.Y. Acad. Sci. 31, 3 (1969)PubMedGoogle Scholar
  66. 102.
    Gould, J.C.: Diskussionsbemerkung zu 106Google Scholar
  67. 103.
    Graber, CD., Higgins, L.S., Davis, J.S.: Seldom-encountered agents of bacterial meningitis. J. Amer. med. Ass. 192, 114 (1965)Google Scholar
  68. 104.
    Graber, CD., Tumbusch, W.T., Rudnicki, R.P., Vogel, E.H.: Generalized Shwartzman-like reaction following Serratia marcescens septicemia in a fatal burn. Surgery 110, 443 (1960)Google Scholar
  69. 105.
    von Graevenitz, A.: Über Serratia-Infektionen beim Menschen. Path. Microbiol. 27, 235 (1964)Google Scholar
  70. 106.
    von Graevenitz, A., Buchholz, D.: Occurrence of Serratia marcescens in soft tissue infection. In: Finland, M., Marget, W., Bartmann, K.: Bacterial infections. Changes in their causative agents. Trends and possible basis, p. 133. Berlin, Heidelberg, New York: Springer 1971Google Scholar
  71. 107.
    Griffith, L.J., Smith, Z.F.: Serratia marcescens as a human pathogen. Bact. Proc. 1963, 73Google Scholar
  72. 108.
    Grimont, P.A.D., Grimont, F., Dulong de Rosnay, H.L.C: Biotyping of nosocomial strains of Serratia: an epidemiological tool. Vortr. Symposium Antisepsis 76, Limburg 10.6.1976Google Scholar
  73. 109.
    Grimont, P.A.D., Grimont, F., Dulong de Rosnay, H.L.C: Characterization of Serratia marcescens, S. liquefaciens, S. plymuthica and S. marinorubra by electrophoresis of their proteinases. J. gen. Microbiol. 99, 301 (1977)Google Scholar
  74. 110.
    Grimont, P.A.D., Grimont, F., Dulong de Rosnay, H.L.C., Sneath, P.H.A.: Taxonomy of the genus Serratia. J. gen. Microbiol. 98, 39 (1977)PubMedGoogle Scholar
  75. 111.
    Haiby, G., McFarland, R.B., Moore, G.H.: Serratia marcescens septicemia. Amer. J. clin. Path. 36, 256 (1961)Google Scholar
  76. 112.
    Hall, A., Inguagiato, G.J., Park, C.: Serratia marcescens septicemia complicating splenectomy in a child. Virginia med. Mth. 98, 605 (1971)Google Scholar
  77. 113.
    Hamon, Y., Péron, Y.: Etude de la propriété bactériocinogène dans le genre Serratia. Ann. Inst. Pasteur 100, 818 (1961)Google Scholar
  78. 114.
    Hartwell, J.L., Shear, M.J., Adams, J.R., Perrault, A.: Chemical treatment of tumors. VII. Nature of the hemorrhage-producing fraction from Serratia marcescens (Bacillus prodigiosus) culture filtrate. J. nat. Cancer Inst. 4, 107 (1943)Google Scholar
  79. 115.
    Hawe, A.J., Hughes, M.H.: Bacterial endocarditis due to Chromobacterium prodigiosan. Report of a case. Brit. med. J. 1954 I, 968Google Scholar
  80. 116.
    Hernández Marchant, R., Oyarce Rojas, P., Arcaya, O.: Sindrome del panal rojo, infectión por Serratia marcescens. Rev. Chil. Pediat. 31, 335 (1960)Google Scholar
  81. 116 a.
    Hoffman, P.C., Arnow, P.M., Goldmann, D.A., Parrott, P.L., Stamm, W.E., McGowan, J.E.: False-positive blood cultures. Association with nonsterile blood collection tubes. J. Amer. med. Ass. 236, 2073 (1976)Google Scholar
  82. 117.
    Hotz, R.M., Dowell, V.R.: Extended study of Serratia in a diagnostic bacteriology laboratory. Canad. J. Microbiol. 12, 99 (1966)Google Scholar
  83. 118.
    Issi, R.: Persönl. Mitteilung 1970Google Scholar
  84. 119.
    Johanson, W.G., Pierce, A.K., Sanford, J.P.: Changing pharyngeal bacterial flora of hospitalized patients. Emergence of gram-negative bacilli. New Engl. J. Med. 281, 1137 (1969)PubMedGoogle Scholar
  85. 120.
    Kaslow, R.A., Mackel, D.C., Mallison, G.F.: Nosocomial pseudobacteremia. Positive blood cultures due to contaminated benzalkonium antiseptic. J. Amer. med. Ass. 236, 2407 (1976)Google Scholar
  86. 121.
    Kass, E.H., Schneiderman, L.J.: Entry of bacteria into the urinary tracts of patients with inlying catheters. New Engl. J. Med. 256, 556 (1957)PubMedGoogle Scholar
  87. 122.
    Kelly, P.J., Wilkowske, C.J., Washington, J.A.: Musculoskeletal infections due to Serratia marcescens. Clin. Orthop. 96, 76 (1973)PubMedGoogle Scholar
  88. 123.
    Kerstan, J., Wolf, H.: Die eitrige Meningitis im Neugeborenen- und Säuglingsalter. Dtsch. med. Wschr. 98, 2060 (1973)PubMedGoogle Scholar
  89. 124.
    Klastersky, J., Hensgens, C., Meunier-Carpentier, F.: Comparative effectiveness of combinations of amikacin with carbenicillin in gram-negative septicemia: double-blind clinical trial. J. infect. Dis. Suppl. 134, 433 (1976)Google Scholar
  90. 125.
    Kourtopoulos, H., Holm, S.E.: Intraventricular treatment of Serratia marcescens meningitis with gentamicin: pharmacokinetic studies of gentamicin concentration in one case. Scand. J. infect. Dis. 8, 57 (1976)PubMedGoogle Scholar
  91. 126.
    Lancaster, L.J.: Role of Serratia species in urinary tract infections. Arch, intern. Med. 109, 536 (1962)Google Scholar
  92. 127.
    Lauras, B., Chavrier, Y., Denis, M., Allantaz, F., Freycon, F.: Epidémie par Serratia marcescens dans une unité de soins intensifs au nouveau-né. Pédiatrie 31, 181 (1967)Google Scholar
  93. 128.
    Laurenzi, G.A., Potter, R.T., Kass, E.H.: Bacteriologie flora of the lower respiratory tract. New Engl. J. Med. 265, 1273 (1961)PubMedGoogle Scholar
  94. 129.
    Magnuson, C.W., Elston, H.R.: Infections caused by nonpigmented Serratia. Report of seven cases. Ann. intern. Med. 65, 409 (1966)PubMedGoogle Scholar
  95. 130.
    Maki, D.G., Hennekens, CG., Phillips, C.W., Shaw, W.V., Bennett, J.V.: Nosocomial urinary tract infection with Serratia marcescens. An epidemiological study. J. infect. Dis. 128, 579 (1973)PubMedGoogle Scholar
  96. 131.
    Marti, H.R.: Krankheiten durch Serratia. In: Gsell, O., Mohr, W.: Infektionskrankheiten, II/2. Berlin, Heidelberg, New York: Springer 1968Google Scholar
  97. 132.
    Maskell, R., Crump, J., Lee, R.: Importance of Serratia marcescens. Lancet 1977 I, 1013Google Scholar
  98. 133.
    McCormack, R.C.; Kunin, C.M.: Control of a single source nursery epidemic due to Serratia marcescens. Pediatrics 37, 750 (1966)PubMedGoogle Scholar
  99. 134.
    McCracken, A.W., Lipscomb, F.E.: Serratia marcescens infection complicating peritoneal dialysis. Brit. med. J. 1965 I, 1536Google Scholar
  100. 135.
    McEntegart, M.G., Porterfield, J.S.: Bacteremia following dental extractions. Lancet 1949 II, 596Google Scholar
  101. 136.
    McLeish, W.A., Elder, R.H., Westwood, J.C.N.: Contaminated vacuum tubes. Canad. med. Ass. J. 112, 682 (1975)PubMedGoogle Scholar
  102. 137.
    Medeiros, A.A., O’Brien, T.F.: Contribution of R factors to the antibiotic resistance of hospital isolates of Serratia. Antimicrob. Agents Chemother. 1968, 30Google Scholar
  103. 138.
    Meltz, D.J., Grieco, M.H.: Characteristics of Serratia marcescens pneumonia. Arch, intern. Med. 132, 359 (1973)Google Scholar
  104. 139.
    Meyer, R.D., Lewis, R.P., Halter, J., White, M.: Gentamicin-resistant Pseudomonas aeruginosa and Serratia marcescens in a general hospitals. Lancet 1976 I, 580Google Scholar
  105. 140.
    Meyers, B.R., Shah, R., Lefkowitz, M.: Mycotic aneurysm of the ascending aorta secondary to Serratia infection: Differentiation from prosthetic valve endocarditis. Chest 65, 215 (1974)PubMedGoogle Scholar
  106. 141.
    Mills, J., Drew, D.: Serratia marcescens endocarditis: A regional illness associated with intravenous drug abuse. Ann. intern. Med. 84, 29 (1976)PubMedGoogle Scholar
  107. 142.
    Milner, P.F.: The differentiation of Enterobacteriaceae infecting the urinary tract. A study in male paraplegics. J. clin. Path. 16, 39 (1963)PubMedGoogle Scholar
  108. 143.
    Modde, H.: Durch Serratia marcescens („Prodigiosus”) verursachte Krankheiten. Schweiz, med. Wschr. 102, 1386 (1972)Google Scholar
  109. 144.
    Modde, H.: Serratia marcescens („B.prodigiosus”), germe d’infections hospitalières. Revue méd. 94, 325 (1974)Google Scholar
  110. 145.
    Monreal, J., Reese, E.T.: The chitinase of Serratia marcescens. Canad. J. Microbiol. 15, 689 (1969)Google Scholar
  111. 146.
    Morse, L.J., Schonbeck, L.E.: Hand lotions — a potential nosocomial hazard. New Engl. J. Med. 278, 376 (1968)PubMedGoogle Scholar
  112. 147.
    Möse, J.R., Pötsch, A.: Über biologische und bakteriostatische Eigenschaften des Prodigiosins und Violaceins. Arch. Hyg. 138, 52 (1954)Google Scholar
  113. 148.
    Myerowitz, R.L., Medeiros, A.A., O’Brien, T.F.: Recent experience with bacillemia due to gram-negative organisms. J. infect. Dis. 124, 239 (1971)PubMedGoogle Scholar
  114. 149.
    Nelms, D.K., Goldman, A.S., O’Donell, A.A., Henry, M.J.: Serratia marcescens osteomyelitis in an infant. J. Pediat. 72, 222 (1968)PubMedGoogle Scholar
  115. 150.
    Paine, T.F.: Illness in man following inhalation of Serratia marcescens. J. infect. Dis. 79, 226 (1946)PubMedGoogle Scholar
  116. 151.
    Pastori, G.: Contributo alio studio del fattore animale negli pseudoprodigi da „Serratia marcescens”. Atti VIII Congr. Naz. Microbiol. Milano 1952, p. 339Google Scholar
  117. 152.
    Pastori, G., Savio, L.: Indagini sperimentali sulla specie batterica Serratia marcescens. III. Indagini sul potere patogeno negli animali da laboratorio. Boll. Soc. ital. Biol. sper. 27, 1507 (1951)PubMedGoogle Scholar
  118. 153.
    Patterson, R.H., Banister, G.B., Knight, V.: Chromobacterial infection in man Arch, intern. Med. 90, 79 (1952)Google Scholar
  119. 154.
    Peloux, Y., Brisou, J.: Chromobactérioses humaines observées à Nouméa. Bull. Soc. Path. exot. 53, 63 (1960)PubMedGoogle Scholar
  120. 155.
    Perrault, A., Shear, M.J.: The bacterial cell of S. marcescens as a source of tumor-necrotizing polysaccharide. Cancer Res. 9, 626 (1949)Google Scholar
  121. 156.
    Peters, M., Caselitz, F.-H., Freitag, V., Nehse, W.: Pyocin- und Marcescinnachweis in der Routinediagnostik. Ärztl. Lab. 21, 372 (1975)Google Scholar
  122. 157.
    Phillips, I., King, A.: Serratia marcescens in hospital practice. Lancet 1977 I, 538Google Scholar
  123. 158.
    Pillich, J., Hradečná, Z., Kocur, M.: An attempt at phage typing in the genus Serratia. J. appl. Bact. 27, 65 (1964)Google Scholar
  124. 159.
    Prévot, A.R.: Manuel de classification et de détermination des bactéries anaérobies, 2 ed. Paris: Masson 1948Google Scholar
  125. 160.
    Prinsloo, H.E.: Bacteriocins and phages produced by Serratia marcescens. J. gen. Microbiol. 45, 205 (1966)PubMedGoogle Scholar
  126. 161.
    Prinsloo, H.E., Coetzee, J.N.: Host-range of temperate Serratia marcescens bacteriophages. Nature 203, 211 (1964)PubMedGoogle Scholar
  127. 162.
    Quintiliani, R.: Endocarditis from Serratia marcescens. J. Amer. med. Ass. 208, 2055 (1969)Google Scholar
  128. 163.
    Rabinowitz, K., Schiffrin, R.: A ward-contamination by Serratia marcescens. Acta med. orient. 11, 181 (1952)PubMedGoogle Scholar
  129. 164.
    Ramsdell, CM., Northup, J.D.: Serratia arthritis: Report of three cases. Sth. med. J. (Bgham, Ala) 66, 889 (1973)Google Scholar
  130. 165.
    Reinlein, J.M.A.: Most frequent microorganisms as a cause of surgical sepsis. Antibiot. Chemother. 21, 22 (1976)Google Scholar
  131. 166.
    Reitman, M., Sutton, L.S., Alg, R.L., Miller, W.S., Gross, N.H.: Agglutinins in sera of laboratory workers exposed to Serratia marcescens. Proc. Soc. exp. Biol. (N.Y.) 89, 236 (1955)Google Scholar
  132. 167.
    Robinson, W., Woolley, P.B.: Pseudohaemoptysis due to Chromobacterium prodigiosum. Lancet 1957 I, 819Google Scholar
  133. 168.
    Roemisch, E., Kocka, F.E.: Comparison of methods for differentiating among Serratia marcescens isolated from clinical specimens. Amer. J. clin. Path. 66, 96 (1976)Google Scholar
  134. 169.
    Rosahn, P.D., Hu, C.K.: Pathogenicity of Serratia marcescens (Bacillus prodigiosus). Proc. Soc. exp. Biol. (N.Y.) 30, 1327 (1932/33)Google Scholar
  135. 170.
    Ross, G.N., Baraff, L.J., Quismorio, F.P.: Serratia arthritis in heroin users. J. Bone Jt Surg. 57 A, 1158 (1975)Google Scholar
  136. 171.
    Schaberg, D.R., Alford, R.H., Anderson, R., Farmer, J.J., Melly, M.A., Schaffner, W.: An outbreak of nosocomial infection due to multiply resistant Serratia marcescens: Evidence of interhospital spread. J. Infect. Dis. 134, 181 (1976)PubMedGoogle Scholar
  137. 172.
    Scheurlen: Geschichtliche und experimentelle Studien über den Prodigiosus. Arch.Hyg. 26, 1 (1896)Google Scholar
  138. 173.
    Schreiner, A., Digranes, A., Myking, O., Solberg, CO.: Wert der transtrachealen Aspiration bei bronchopulmonalen Infektionen im Erwachsenenalter. Infection 1, 1370973)Google Scholar
  139. 174.
    Sciaky, I., Drimmer, H.: Pathogenicity of Serratia marcescens in pulpitis. Oral Surg. 15, 91 (1962)Google Scholar
  140. 175.
    Seneca, H., Grant, J.P.: Gram-negative sepsis and endotoxic shock. Antibiot. Chemother. 21, 52 (1976)PubMedGoogle Scholar
  141. 176.
    Shear, M.J., Perrault, A.: Chemical treatment of tumors. IX. Reactions of mice with primary subcutaneous tumors to injection of a hemorrhage-producing bacterial polysaccharide. J. nat. Cancer Inst. 4, 461 (1944)Google Scholar
  142. 177.
    Shear, M.J., Turner, F.C: Studies on chemical treatment of tumors. V. Separation of the hemorrhage-producing fraction from Bacillus prodigiosus filtrates. J. biol. Chem. 133, 87 (1940)Google Scholar
  143. 178.
    Slotnick, I.J., Dougherty, M.: Erythritol as a selective substrate for the growth of Serratia marcescens. Appl. Microbiol. 24, 292 (1972)PubMedGoogle Scholar
  144. 179.
    Spiegel, Hamburg: Enorme Bedrohung für die Welt. 1977/21, 137Google Scholar
  145. 180.
    Stamm, W.E., Kolff, CA., Muñoz Dones, E., Javariz, R., Anderson, R.L., Farmer, J.J., Rivera de Quinones, H.: A nursery outbreak caused by Serratia marcescens — scalp vein needles as a portal of entry. J. Pediat. 89, 96 (1976)PubMedGoogle Scholar
  146. 180a.
    Stamm, W.E., Martin, S.M., Bennett, J.V.: Epidemiology of nosocomial infections due to gram-negative bacilli: Aspects relevant to development and use of vaccines. J. infect. Dis. 136, S151 (1977)PubMedGoogle Scholar
  147. 181.
    Stenderup, A., Faergeman, O., Ingerslev, M.: Serratia marcescens infections in premature infants. Acta path, microbiol. scand. 68, 157 (1966)Google Scholar
  148. 182.
    Tabaqchali, S., Chambers, T.J., Brooks, H.J.L.: Serratia marcescens in hospital practice. Lancet 1977 I, 306Google Scholar
  149. 183.
    Tally, F.P., Louie, T.J., O’Keefe, J.P., Gorbach, S.L., Bartlett, J.G.: Amikacin therapy for severe gram-negative sepsis: Efficacy in infections involving gentamicin-resistant organisms. J. infect. Dis. Suppl. 134, 428 (1976)Google Scholar
  150. 184.
    Thomas, F.E., Leonard, J.M., Alford, R.H.: Sulfamethoxazoletrimethoprimpolymyxin therapy of serious multiplv drug-resistant Serratia infections. Antimicrob. Agents Chemother. 9, 201 (1976)PubMedGoogle Scholar
  151. 185.
    Thomas, L., Good, R.A.: Studies on the generalized Shwartzman reaction. I. General observations concerning the phenomenon. J. exp. Med. 96, 605 (1952)PubMedGoogle Scholar
  152. 186.
    Thornton, G.F., Andriole, V.T.: Antibiotic sensitivities of nonpigmented Serratia marcescens to gentamicin and carbenicillin. J. infect. Dis. 119, 393 (1969)PubMedGoogle Scholar
  153. 187.
    Traub, W.H.: Über die Bedeutung von Serratia marcescens als opportunistischer Krankheitserreger. Münch. med. Wschr. 115, 128 (1973)Google Scholar
  154. 188.
    Traub, W.H., Kleber, I.: Detection of fibrinolytic and elastase activity among clinical isolates of Serratia marcescens. Path. Microbiol. 41, 334 (1974)Google Scholar
  155. 189.
    Traub, W.H., Raymond, E.A.: Epidemiological surveillance of Serratia marcescens infections by bacteriocin typing. Appl. Microbiol. 22, 1058 (1971)PubMedGoogle Scholar
  156. 190.
    Traub, W.H., Raymond, E.A., Startsman, T.S.: Bacteriocin (marcescin) typing of clinical isolates of Serratia marcescens. Appl. Microbiol. 21, 837 (1971)PubMedGoogle Scholar
  157. 191.
    Tumulka, A., Kaplan, R.W.: Mutagene Wirkung des Contergans (Thalidomid) bei Bakterien. Naturwissenschaften 52, 20 (1965)Google Scholar
  158. 192.
    Vandepitte, J.M., Verbist, L., Meeussen, L.: Sensitivity of hospital strains of Serratia marcescens to aminoglycosides. Acta clin. belg. 31, 153 (1976)PubMedGoogle Scholar
  159. 193.
    Verbist, L.: Comparison of the antibacterial activity of nine cephalosporins against Enterobacteriaceae and nonfermentative gram-negative bacilli. Antimicrob. Agents Chemother. 10, 657 (1976)PubMedGoogle Scholar
  160. 194.
    Verbist, L., Spaepen, J., Vandepitte, J.: In vitro sensitivity of hospital strains of Serratia marcescens to chemotherapeutic agents. Chemotherapy 22, 43 (1976)PubMedGoogle Scholar
  161. 195.
    Waisman, H.A., Stone, W.H.: The presence of Serratia marcescens as the predominating organism in the intestinal tract of the newborn. The occurrence of the “red diaper syndrome”. Pediatrics 21, 8 (1958)PubMedGoogle Scholar
  162. 196.
    Washington, J.A.: Comparison of two commercially available media for detection of bacteremia. Appl. Microbiol. 22, 604 (1971)PubMedGoogle Scholar
  163. 197.
    Washington, J.A.: The microbiology of evacuated blood collection tubes. Ann. intern. Med. 86, 186 (1977)PubMedGoogle Scholar
  164. 198.
    Wassermann, M.M., Seligmann, E.: Serratia marcescens bacteriophages. J. Bact. 66, 119 (1953)PubMedGoogle Scholar
  165. 199.
    Wheat, R.P., Zuckerman, A., Rantz, L.A.: Infection due to chromobacteria. Arch. intern. Med. 88, 461 (1951)Google Scholar
  166. 200.
    Whitby, J.L., Blair, J.N., Rampling, A.: Cross-infection with Serratia marcescens in an intensive therapy unit. Lancet 1972 II, 127Google Scholar
  167. 201.
    Wilfert, J.N., Barrett, F.F., Ewing, W.H., Finland, M., Kass, E.H.: Serratia marcescens: Biochemical, serological, and epidemiological characteristics and antibiotic susceptibility of strains isolated at Boston City Hospital. Appl. Microbiol. 19, 345 (1970)PubMedGoogle Scholar
  168. 202.
    Wilfert, J.N., Barrett, F.F., Kass, E.H.: Bacteremia due to Serratia marcescens. New Engl. J. Med. 279, 286 (1968)PubMedGoogle Scholar
  169. 203.
    Wilkowske, C.J., Washington, J.A., Martin, W.J., Ritts, R.E.: Serratia marcescens. Biochemical characteristics, antibiotic susceptibility pattern, and clinical significance. J. Amer. med. Ass. 214, 2157 (1970)Google Scholar
  170. 204.
    Wollstein, M., Meltzer, S.J.: The lesions produced by intra-bronchial insufflations of B. prodigiosus. Science 38, 452 (1913)Google Scholar
  171. 205.
    Woodward, H.M.M., Clarke, K.B.: A case of infection in man by the Bacterium prodigiosum. Lancet 1913 I, 314Google Scholar
  172. 206.
    Wright, C., Kominos, S.D., Yee, R.B.: Enterobacteriaceae and Pseudomonas aeruginosa recovered from vegetable salads. Appl. Microbiol. 31, 453 (1976)Google Scholar
  173. 207.
    Wysocki, S.: Diskussionsbemerkung zu 106Google Scholar

Erwinia

  1. 208.
    Ansorg, R., Thomssen, R., Stubbe, P.: Erwinia Species bei letaler Neugeborenensepsis. Med. Microbiol. Immunol. 159, 161 (1974)PubMedGoogle Scholar
  2. 209.
    Ansorg, R., Thomssen, R., Stubbe, P.: Flower vases and pathogens. Lancet 1974 I, 621Google Scholar
  3. 210.
    Baumgärtel, T.: Über ein farbstoffbildendes Bacterium der Typhus-Coligruppe. Z. Hyg. 85, 367 (1918)Google Scholar
  4. 211.
    Beijerinck, M.W., Rant, A.: Wundreiz, Parasitismus und Gummifluss bei den Amygdaleen. Zbl. Bakt., II. Abt. 15, 366 (1906)Google Scholar
  5. 212.
    Bhat, P., Shanthakumari, S., Myers, R.M.: Detection of “Chromobacterium” typhi-flavum in stool specimens. Indian. J. med. Res. 60, 991 (1972)PubMedGoogle Scholar
  6. 213.
    Billing, E., Baker, L.A.E.: Characteristics of Erwinia-like organisms found in plant material. J. appl. Bact. 26, 58 (1963)Google Scholar
  7. 214.
    Bottone, E., Schneierson, S.S.: Erwinia species: An emerging human pathogen. Amer. J. clin. Path. 57, 400 (1972)Google Scholar
  8. 215.
    Botzenhart, K., Kufferath, R.: Über die Vermehrung verschiedener Enterobacteriaceae sowie Pseudomonas aeruginosa und Alkaligenes spec, in destilliertem Wasser, entionisiertem Wasser, Leitungswasser und Mineralsalzlösung. Zbl. Bakt. Hyg., I. Abt. Orig. B 163, 470 (1976)Google Scholar
  9. 216.
    Brenner, D.J., Fanning, G.R., Steigerwalt, A.G.: Deoxyribonucleic acid relatedness among Erwiniae and other Enterobacteriaceae: The gall, wilt, and dry-necrosis organisms (genus Erwinia Winslow et al., sensu stricto). Int. J. syst. Bacteriol. 24, 197 (1974)Google Scholar
  10. 217.
    Brenner, D.J., Steigerwalt, A.G., Miklos, G.V., Fanning, G.R.: Deoxyribonucleic acid relatedness among Erwiniae and other Enterobacteriaceae: The soft-rot organisms (genus Pectobacterium Waldee). Int. J. syst. Bacteriol. 23, 205 (1973)Google Scholar
  11. 218.
    Brisou, J., Tysset, C., Vacher, B.: Étude d’une souche d’Erwinia (Erwinia salmonis nv. sp.) isolée d’une truite commune (Salmo fario L). Ann. Inst. Pasteur 97, 241 (1959)Google Scholar
  12. 219.
    Center for Disease Control: Nosocomial bacteremias associated with intravenous fluid therapy — USA. Morbid. Mortal. Weekly Rep. 20, Spec. Suppl. to No. 9 (1971)Google Scholar
  13. 220.
    Center for Disease Control: Follow-up on septicemias associated with contaminated Abbott intravenous fluids — United States. Morbid. Mortal. Weekly Rep. 20, 91 (1971)Google Scholar
  14. 221.
    Center for Disease Control: Septicemias associated with contaminated intravenous fluids — Wisconsin, Ohio. Morbid. Mortal. Weekly Rep. 22, 99 (1973)Google Scholar
  15. 222.
    Center for Disease Control: Follow-up on septicemias associated with contaminated intravenous fluids — United States. Morbid. Mortal. Weekly Rep. 22, 115 (1973)Google Scholar
  16. 223.
    Cocks, G.T., Wilson, A.C.: Enzyme evolution in the Enterobacteriaceae. J. Bact. 110, 793 (1972)PubMedGoogle Scholar
  17. 224.
    Cruickshank, J.C.: A study of the so-called Bacterium typhi flavum. J. Hyg. (Lond.) 35, 354 (1935)Google Scholar
  18. 225.
    Daschner, F., Marget, W.: Infektionsgefährdung von Klinikpatienten durch therapeutische Maßnahmen. Münch. med. Wschr. 118, 545 (1976)Google Scholar
  19. 226.
    Dresel, E.G.: Zur Epidemiologie des Bact. typhi flavum. Zbl. Bakt., I. Abt. Orig. 122, 158 (1931)Google Scholar
  20. 227.
    Dresel, E.G., Stickl, O.: Über reversible Mutationsformen der Typhusbazillen beim Menschen. Dtsch. med. Wschr. 54, 517 (1928)Google Scholar
  21. 228.
    Düggeli, M.: Die Bakterienflora gesunder Samen und daraus gezogener Keimpflänzchen. Zbl. Bakt., II. Abt. 12, 602, 695 (1904)Google Scholar
  22. 228a.
    Düggeli, M.: Die Bakterienflora gesunder Samen und daraus gezogener Keimpflänzchen. Zbl. Bakt., II. Abt. 13, 56, 198 (1904)Google Scholar
  23. 229.
    Dutkiewicz, J.: Studies on endotoxins of Erwinia herbicola and their biological activity. Zbl. Bakt. Hyg., I. Abt. Orig. A 236, 487 (1976)Google Scholar
  24. 230.
    Edwards, P.R., Ewing, W.H.: Identification of Enterobacteriaceae, 3. Ed. Minneapolis: Burgess 1972Google Scholar
  25. 231.
    Eisenberg, P.: Untersuchungen über die Variabilität der Bakterien. VI. Mitteilung: Variabilität in der Typhus-Coli-Gruppe. Zbl. Bakt., I. Abt. Orig. 80, 385 (1918)Google Scholar
  26. 232.
    Ewing, W.H., Fife, M.A.: Enterobacter agglomerans (Beijerinck) comb. nov. (the Herbicola-Lathyri bacteria). Int. J. syst. Bacteriol. 22, 4 (1972)Google Scholar
  27. 233.
    Felts, S.K., Schaffner, W., Melly, M.A., Koenig, M.G.: Sepsis caused by intravenous fluids. Epidemiologic, clinical and laboratory investigation of an outbreak in one hospital. Ann. intern. Med. 77, 881 (1972)PubMedGoogle Scholar
  28. 234.
    v. Gara, P., Stickl, O.: Über das Bacterium typhi flavum und seine Beziehungen zum typischen Bacterium typhi Eberth-Gaffky. Zbl. Bakt., I. Abt. Orig. 117, 38 (1930)Google Scholar
  29. 235.
    Gardner, J.M., Kado, C.I.: Comparative base sequence homologies of the deoxyribonucleic acids of Erwinia species and other Enterobacteriaceae. Int. J. syst. Bacteriol. 22, 201 (1972)Google Scholar
  30. 236.
    Geere, I.W.: Enterobacter agglomerans: the clinically important plant pathogen. Canad. med. Ass. J. 116, 517 (1977)PubMedGoogle Scholar
  31. 237.
    Gelbart, S.M., Reinhardt, G.F., Greenlee, H.B.: Multiplication of nosocomial pathogens in intravenous feeding solutions. Appl. Microbiol. 26, 874 (1973)PubMedGoogle Scholar
  32. 238.
    Gilardi, G.L., Bottone, E.: Erwinia and yellow-pigmented Enterobacter isolates from human sources. Antonie v. Leeuwenhoek 37, 529 (1971)Google Scholar
  33. 239.
    Gilardi, G.L., Bottone, E., Birnbaum, M.: Unusual fermentative, Gram-negative bacilli isolated from clinical specimens. I. Characterization of Erwinia strains of the “lathyri-herbicola Group”. Appl. Microbiol. 20, 151 (1970)PubMedGoogle Scholar
  34. 240.
    Goldmann, D.A., Maki, D.G., Rhame, F.S., Kaiser, A.B., Tenney, J.H., Bennett, J.V.: Guidelines for infection control in intravenous therapy. Ann. intern. Med. 79, 848 (1973)Google Scholar
  35. 241.
    v. Graevenitz, A.: Erwinia species isolates. Ann. N.Y. Acad. Sci. 174, 436 (1970)Google Scholar
  36. 242.
    v. Graevenitz, A.: Recognition and differential diagnosis of Erwinia herbicola strains isolated in the hospital. Path. Microbiol. 37, 84 (1971)Google Scholar
  37. 243.
    v. Graevenitz, A.: Erwinia infection from environmental sources. J. Amer. med. Ass. 216, 1485 (1971)Google Scholar
  38. 244.
    v. Graevenitz, A.: Humanmedizinische Aspekte der Herbicola-Lathyri-Bakterien. Vortr. 4. Arbeitstgg. Dtsch. Ges. Hyg. Mikrobiol., Mainz 1972Google Scholar
  39. 245.
    v. Graevenitz, A., Strouse, A.: Isolation of Erwinia spp. from human sources. Antonie v. Leeuwenhoek 32, 429 (1966)Google Scholar
  40. 246.
    Graham, D.C., Hodgkiss, W.: Identity of Gram negative, yellow pgimented, fermentative bacteria isolated from plants and animals. J. appl. Bact. 30, 175 (1967)Google Scholar
  41. 247.
    Gram, E., Bovien, P., Stapel, C.: Farbtafelatlas der Krankeiten und Schädlinge an landwirtschaftlichen Kulturpflanzen. Berlin, Hamburg: Parey 1956Google Scholar
  42. 248.
    Harrison, A., Gibbins, L.N.: The isolation and characterization of a temperate phage, Y 46/(E 2), from Erwinia herbicola Y 46. Canad. J. Microbiol. 21, 937 (1975)Google Scholar
  43. 249.
    Hérin, N., Ledoux, L.: Mise en évidence d’une bactériocine chez Erwinia uredovora. Arch. Int. Physiol. Biochim. 84, 627 (1976)PubMedGoogle Scholar
  44. 250.
    Hirsch, W.: Über das sogenannte „Bacterium typhi flavum”. Zbl. Bakt., I. Abt. Orig. 128, 413 (1933)Google Scholar
  45. 251.
    v. Hövell, H.: Über eine neue Gruppe typhusähnlicher, farbstoffbildender Bakterien. Zbl. Bakt., I. Abt. Orig. 77, 449 (1916)Google Scholar
  46. 252.
    Huss, H.: Morphologisch-physiologische Studien über zwei aromabildende Bakterien. Zbl. Bakt., II. Abt. 19, 50, 149 (1907)Google Scholar
  47. 253.
    Kathe, H.: Diskussion zu Dresel, E.G., 226Google Scholar
  48. 254.
    Kathe, H.: Über besondere Wuchsformen der sogenannten Gelbkeime. Zbl. Bakt., I. Abt. Orig. 128, 437 (1933)Google Scholar
  49. 255.
    Kauffmann, F.: Diskussion zu Dresel, E.G., 226Google Scholar
  50. 256.
    Kirchner, H.-A.: Grundriß der Phytopathologie und des Pflanzenschutzes, 2. Aufl. Jena: VEB Fischer 1975Google Scholar
  51. 257.
    Köhlisch: Gelbwachsende, den Bacillen der Typhus-Paratyphus-Gruppe ähnliche Bakterien. Zbl. Bakt., I. Abt. Orig. 78, 136 (1916)Google Scholar
  52. 258.
    Komogata, K., Tamagawa, Y., Iizuka, H.: Characteristics of Erwinia herbicola. J. gen. appl. Microbiol. 14, 19 (1968)Google Scholar
  53. 259.
    Kramer, E.: Diskussion zu Dresel, E.G., 226Google Scholar
  54. 260.
    Krishnan, C., Goldie, V.J.: Human infection with Bacterium typhiflavum. Bact. Proc. 1968, 102Google Scholar
  55. 261.
    Lelliott, R.A.: Genus Erwinia. In: Buchanan, R.E., Gibbons, N.E.: Bergey’s Manual of Determinative Bacteriology, 8. Ed. Baltimore: Williams & Wilkins 1974Google Scholar
  56. 262.
    Lentz: Diskussion zu Dresel, E.G., 226Google Scholar
  57. 263.
    Lev, M., Alexander, R.H., Soebel, H.J.: A study of Chromobacterium typhiflavum from the rat. J. appl. Bact. 32, 429 (1969)Google Scholar
  58. 264.
    de Ley, J.: DNA base composition of yellow Erwinia strains. Antonie v. Leeuwenhoek 34, 257 (1968)Google Scholar
  59. 265.
    Lockhart, W.R., Koenig, K.: Use of secondary data in numerical taxonomy of the genus Erwinia. J. Bact. 90, 1638 (1965)PubMedGoogle Scholar
  60. 266.
    Mack, E.: Untersuchungen über Bacterium herbicola. Zbl. Bakt., II. Abt. 95, 218 (1936/37)Google Scholar
  61. 267.
    Mackel, D.C., Maki, D.G., Anderson, R.L., Rhame, F.S., Bennett, J.V.: Nationwide epidemic of septicemia caused by contaminated intravenous products: Mechanisms of intrinsic contamination. J. clin. Microbiol. 2, 486 (1975)PubMedGoogle Scholar
  62. 268.
    Maki, D.G., Martin, W.T.: Nationwide epidemic of septicemia caused by contaminated infusion products. IV. Growth of microbial pathogens in fluids for intravenous infusion. J. infect. Dis. 131, 267 (1975)PubMedGoogle Scholar
  63. 269.
    Maki, D.G., Goldmann, D.A., Rhame, F.S.: Infection control in intravenous therapy. Ann. intern. Med. 79, 867 (1973)PubMedGoogle Scholar
  64. 270.
    Maki, D.G., Rhame, F.S., Mackel, D.C., Bennett, J.V.: Nationwide epidemic of septicemia caused by contaminated intravenous products. I. Epidemiologic and clinical features. Amer. J. Med. 60, 471 (1976)PubMedGoogle Scholar
  65. 271.
    Meers, P.D., Calder, M.W., Mazhar, M.M., Lawrie, G.M.: Intravenous infusion of contamined dextrose solution. The Devonport incident. Lancet 1973 II, 1189Google Scholar
  66. 272.
    Meyers, B.R., Bottone, E., Hirschman, S.Z., Schneierson, S.S.: Infections caused by microorganisms of the genus Erwinia. Ann. intern. Med. 76, 9 (1972)PubMedGoogle Scholar
  67. 273.
    Muraschi, T.F., Friend, M., Bolles, D.: Erwinia-like microorganisms isolated from animal and human hosts. Appl. Microbiol. 13, 128 (1965)PubMedGoogle Scholar
  68. 274.
    Obrtel, J.: 1st das B. typhi flavum pathogen? Zbl. Bakt., I. Abt. Ref. 104, 387 (1932)Google Scholar
  69. 275.
    Pangalos, G.: Sur un bacille chromogène isolé par hémoculture, C.R. Soc. Biol. 100, 1097 (1929)Google Scholar
  70. 276.
    Potrikus, C.J., Breznak, J.A.: Nitrogen-fixing Enterobacter agglomerans isolated from guts of wood-eating termites. Appl. Environm. Microbiol. 33, 392 (1977)Google Scholar
  71. 277.
    Prats, G., Llobet, J.M., Pericas, R., Mirelis, B., Ausina, V., Sarda, Z.: Sepsis por Enterobacter agglomerans Erwinia herbicola. Rev. clin. esp. 141, 285 (1976)PubMedGoogle Scholar
  72. 278.
    Roberts, J., Schmid, F.A., Old, L J., Stockert, E.: A comparative study of the antitumor effectiveness of E. coli and Erwinia asparaginases. Cancer Biochem. Biophys. 1, 175 (1976)PubMedGoogle Scholar
  73. 279.
    Schaad, N.W.: Comparative immunology of ribosomes and disc gel electrophoresis of ribosomal proteins from Erwiniae, Pectobacteria, and other members of the family Enterobacteriaceae. Int. J. syst. Bacteriol. 24, 42 (1974)Google Scholar
  74. 280.
    Schaede: Über das Wachstum des sogenannten Bacterium typhi flavum in Blut und Galle. Zbl. Bakt., I. Abt. Orig. 130, 21 (1933/34)Google Scholar
  75. 281.
    Schütz, F., Laun, H.: Über einen seltenen Bakterienbefund im menschlichen Abszeßeiter. Zbl. Bakt., I. Abt. Orig. 129, 124 (1933)Google Scholar
  76. 282.
    Seydel, J.: Sur les propriétés biochimiques et sérologiques du B. typhi flavum. Ann. Inst. Pasteur 52, 179 (1934)Google Scholar
  77. 283.
    Seiler, H., Busse, M.: Taxonomische Bedeutung von Gärbilanzen bei Enterobacteriaceae. Zbl. Bakt. Hyg., I. Abt. Orig. A 236, 36 (1976)Google Scholar
  78. 284.
    Slotnick, I.J., Tulman, L.: A human infection caused by an Erwinia species. Amer. J.Med. 43, 147 (1967)PubMedGoogle Scholar
  79. 285.
    Sobin, B., Stahly, G.L.: The isolation ahd absorption spectrum maxima of bacterial carotenoid pigments. J. Bact. 44, 265 (1942)PubMedGoogle Scholar
  80. 286.
    Sonnenschein, C.: Untersuchung von Stämmen des sogenannten Bacterium typhi flavum. Zbl. Bakt., I. Abt. Orig. 119, 259 (1930/31)Google Scholar
  81. 287.
    Sonnenschein, C.: Diskussion zu Dresel, E.G., 226Google Scholar
  82. 288.
    Starr, M.P., Chatterjee, A.K.: The genus Erwinia: Enterobacteria pathogen to plants and animals. Ann. Rev. Microbiol. 26, 389 (1972)Google Scholar
  83. 289.
    Starr, M.P., Mandel, M.: DNA base composition and taxonomy of phytopathogenic and other enterobacteria. J. gen. Microbiol. 56, 113 (1969)PubMedGoogle Scholar
  84. 290.
    Steigerwalt, A.G., Fanning, G.R., Fife-Asbury, M.A., Brenner, D.J.: DNA relatedness among species of Enterobacter and Serratia. Canad. J. Microbiol. 22, 121 (1976)Google Scholar
  85. 291.
    Stickl, O.: Zur Pathologie und Klinik des Bact. typhi flavum. Zbl. Bakt., I. Abt. Orig. 122, 156 (1931)Google Scholar
  86. 292.
    Taylor, A.J.: Isolation and identification of Erwinia in a hospital laboratory. Med. Lab. Technol. 31, 37 (1974)PubMedGoogle Scholar
  87. 293.
    Tilton, R.C., Murphy, J.R., van Soestbergen, A.: Erwinia species from human sources. Amer. J. clin. Path. 56, 187 (1971)Google Scholar
  88. 294.
    Urmenyi, A.M.C., Franklin, A.W.: Neonatal death from pigmented conform infection. Lancet 1961 I, 313Google Scholar
  89. 295.
    Ursing, J.: Characterization of Enterobacter agglomerans (Erwinia spp.) from clinical specimens. Acta path, microbiol. scand. Sect. B. 85, 61 (1977)Google Scholar
  90. 296.
    Villanueva Castro, U.: Über das Vorkommen von Gelbkeimen des sogenannten Bact. typhi flavum in der Umwelt. Untersuchung von 76 Gelbkeimstämmen. Dtsch. med. Wschr. 60, 1014 (1934)Google Scholar
  91. 297.
    Wámoscher, L.: Über atypische Bakterienformen und ihre Bedeutung. Zbl. Bakt., I. Abt. Orig. 127, 138 (1933)Google Scholar
  92. 298.
    Wechsler, A., Bottone, E., Lasser, R., Korenman, G.: Brain abscess caused by an Erwinia species. Report of a case and review of the literature. Amer. J. Med. 51, 680 (1971)PubMedGoogle Scholar
  93. 299.
    Weiner, M., Werthamer, S.: Opportunistic infections with Erwinia-like species. N.Y. St. J. Med. 73, 2256 (1973)Google Scholar
  94. 300.
    Wolff, A.: Zur Frage nach den Beziehungen zwischen Bakterienflora der Milch und der Weide. Zbl. Bakt., II. Abt. 39, 411 (1913/14)Google Scholar
  95. 301.
    Wright, C., Kominos, S.D., Yee, R.B.: Enterobacteriaceae and Pseudomonas aeruginosa recovered from vegetable salads. Appl. Environm. Microbiol. 31, 453 (1976)Google Scholar

Flavobacterium

  1. 302.
    Agarwal, K.C., Ray, M.: Meningitis in a newborn due to Flavobacterium meningosepticum. Indian J. Med. 59, 1006 (1971)Google Scholar
  2. 303.
    Altmann, G., Bogokovsky, B.: In-vitro sensitivity of Flavobacterium meningosepticum to antimicrobial agents. J. med. Microbiol. 4, 296 (1971)PubMedGoogle Scholar
  3. 304.
    Bagley, D.H., Alexander, J.C., Gill, V.J., Dolin, R., Ketcham, A.S.: Late Flavobacterium species meningitis after craniofacial exenteration. Arch. intern. Med. 136, 229 (1976)Google Scholar
  4. 305.
    Berry, W.B., Morrow, A.G., Harrison, D.C., Hochstein, H.D., Himmelsbach, C.K.: Flavobacterium septicemia following intracardiac operations. J. thorac. cardiovasc. Surg. 45, 476 (1963)Google Scholar
  5. 306.
    Biegleisen, J., Marcus, B., Cherry, W.A.: (1961) zit. nach Vandepitte, J. et al. (1965)Google Scholar
  6. 307.
    Brody, J.A., Moore, H., King, E.O.: Meningitis caused by an unclassified gramnegative bacterium in newborn infants. Amer. J. Dis. Child.96, 1 (1958)Google Scholar
  7. 308.
    Buttiaux, R., Vandepitte, J.: Les Flavobacterium dans les méningites épidémiques des nouveau-nés. Ann. Inst. Pasteur 98, 398 (1960)Google Scholar
  8. 309.
    Cabrera, H.A., Davis, G.H.: Epidemie meningitis of the newborn caused by Flavobacteria. Amer. J. Dis. Child. 101, 289 (1961)PubMedGoogle Scholar
  9. 310.
    Coyle-Gilchrist, M.M., Crewe, P., Roberts, G.: Flavobacterium meningosepticum in the hospital environment. J. clin. Path. 29, 824 (1976)PubMedGoogle Scholar
  10. 311.
    Duma, R.J., Warner, J.F., Dalton, H.P.: Septicemia from intravenous infusions. New Engl. J. Med. 284, 257 (1971)PubMedGoogle Scholar
  11. 312.
    DuPont, H.L., Spink, W.W.: Infections due to gram-negative organisms: An analysis of 860 patients with bacteremia at the university of Minnesota Medical Center, 1958–1966. Medicine (Baltimore) 48, 307 (1969)Google Scholar
  12. 313.
    Editorial: Water bugs in the bassinet. Amer. J. Dis. Child. 101, 273 (1961)Google Scholar
  13. 314.
    Eeckels, R., Vandepitte, J., Seynhaeve, V.: Neonatal infections with Flavobacterium meningosepticum. Belg. T. Geneesk. 5, 244 (1965)Google Scholar
  14. 315.
    Ehrlich, R., Miller, S., Walker, R.L.: Effects of atmospheric humidity and temperature on the survival of airborne Flavobacterium. Appl. Microbiol. 20, 884 (1970)PubMedGoogle Scholar
  15. 316.
    Eykens, A., Eggermont, E., Eeckels, R.: Neonatal meningitis caused by Flavobacterium meningosepticum. Helv. paediat. Acta 28, 421 (1973)PubMedGoogle Scholar
  16. 317.
    Favero, M.S., Carson, L.A., Bond, W.W., Petersen, N.J.: Pseudomonas aeruginosa: Growth in destilled water from hospitals. Science 173, 836 (1971)PubMedGoogle Scholar
  17. 318.
    Gardener, P., Griffin, W.B., Swartz, M.N., Kunz, L.J.: Nonfermentative gramnegative bacilli of nosocomial interest. Amer. J. Med. 48, 735 (1970)Google Scholar
  18. 319.
    George, R.M., Cochran, C.P., Wheeler, W.E.: Epidemic meningitis of the newborn caused by Flavobacteria. Amer. J. Dis. Child. 101, 296 (1961)PubMedGoogle Scholar
  19. 320.
    v. Graevenitz, A., Grehn, M.: Züchtung und Differenzierung obligat aerober gramnegativer Stäbchen aus menschlichem Untersuchungsmaterial. Schema zur Anwendung in der Routinediagnostik. Zbl. Bakt. Hyg., I. Abt. Orig. A 236, 513 (1976)Google Scholar
  20. 321.
    Greaves, P.W.: Isolation of bacteria resembling Flavobacterium meningosepticum from human material in Britain. J. med. Lab. Technol. 23, 115 (1966)PubMedGoogle Scholar
  21. 322.
    Harrison, H.: zit. nach Editorial (1961)Google Scholar
  22. 323.
    Hawley, H.B., Gump, D.W.: Vancomycin therapy of bacterial meningitis. Amer. J. Dis. Child. 126, 261 (1973)PubMedGoogle Scholar
  23. 323 a.
    Hazuka, B.T., Dajani, A.S., Talbot, K., Keen, B.M.: Two outbreaks of Flavobacterium meningosepticum type E in a neonatal intensive care unit. J. clin. Microbiol. 6, 450 (1977)PubMedGoogle Scholar
  24. 324.
    Herman, L.G., Himmelsbach, CK.: Detection and control of hospital sources of flavobacteria. J. Amer. Hosp. Ass. 39, 72 (1965)Google Scholar
  25. 325.
    Kleemann, CR., Hewitt, W.L., Guze, L.B.: Pyelonephritis. Medicine (Baltimore) 39, 3 (1960)Google Scholar
  26. 326.
    King, E.O.: Studies on a group of previously unclassified bacteria associated with meningitis in infants. Amer. J. clin. Path. 31, 241 (1959)Google Scholar
  27. 327.
    King, E.O.: Round Table: Current trends in diagnostic microbiology. Atlanta: C.D.C. 1967Google Scholar
  28. 328.
    Kresky, B.: Control of gram-negative bacilli in a hospital nursery. Amer. J. Dis. Child. 107, 363 (1964)PubMedGoogle Scholar
  29. 329.
    Lapage, S.P., Owen, R.J.: Flavobacterium meningosepticum from cases of meningitis in Botswana and England. J. clin. Path. 26, 747 (1973)PubMedGoogle Scholar
  30. 330.
    Lee, E.L., Robinson, M.J., Thong, M.L., Puthucheary, S.D.: Rifamycin in neonatal Flavobacteria meningitis. Arch. Dis. Childh. 51, 209 (1976)PubMedGoogle Scholar
  31. 331.
    LeFrancois, M., Baum, J.L.: Flavobacterium endophthalmitis following keratoplasty. Use of a tissue culture medium-stored cornea. Arch. Ophthal. 49, 1907 (1976)Google Scholar
  32. 332.
    Lewis, J., Fekety, F.R.: Gram-negative bacteremia. Johns Hopk. med. J. 124, 106 (1969)Google Scholar
  33. 333.
    Maderazo, E.G., Bassaris, H.P., Quintiliani, R.: Flavobacterium meningosepticum in a newborn infant. Treatment with intraventricular erythromycin. J. Pediat. 85, 675 (1974)PubMedGoogle Scholar
  34. 334.
    Madruga, M., Zanom, U., Pereira, G.M.N., Galvão, A.C.: Meningitis caused by Flavobacterium meningosepticum. The first epidemic outbreak of meningitis in the newborn in South America. J. infect. Dis. 121, 328 (1970)PubMedGoogle Scholar
  35. 335.
    McCracken, G.H.: The rate of bacteriologie response to antimicrobial therapy in neonatal meningitis. Amer. J. Dis. Child. 123, 547 (1972)PubMedGoogle Scholar
  36. 336.
    McMeekin, T.A., Patterson, J.T., Murray, J.G.: An initial approach to the taxonomy of some gram negative yellow pigmented rods. J. appl. Bact. 34, 699 (1971)Google Scholar
  37. 337.
    McMeekin, T.A., Stewart, D.B., Murray, J.G.: The Adansonian taxonomy and the deoxyribonucleic acid base composition of some gram negative yellow pigmented rods. J. appl. Bact. 35, 129 (1972)Google Scholar
  38. 338.
    Minocycline: Lederle Lab., Cyanamid Co., Pearl River—New York 1971Google Scholar
  39. 339.
    Olsen, H.: The importance of temperature for the growth of Flavobacterium meningosepticum. Acta path, microbiol. scand. B 67, 291 (1966)Google Scholar
  40. 340.
    Olsen, H.: A clinical analysis of 10 cases of postoperative infection with Flavobacterium meningosepticum. Dan. med. Bull. 14, 1 (1967)PubMedGoogle Scholar
  41. 341.
    Olsen, H.: An epidemiological study of hospital infections with Flavobacterium meningosepticum. Dan. med. Bull. 14, 6 (1967)PubMedGoogle Scholar
  42. 342.
    Olsen, H.: An in vitro study of the antibiotic sensitivity of Flavobacterium meningosepticum. Acta path, microbiol. scand. B 70, 601 (1967)Google Scholar
  43. 343.
    Olsen, H.: The sensitivity of Flavobacterium meningosepticum to antibiotics at different temperatures. Acta path, microbiol. scand. B 71, 592 (1967)Google Scholar
  44. 344.
    Olsen, H.: Flavobacterium meningosepticum isolated from outside hospital surroundings and during routine examination of patient specimens. Acta path. microbiol. scand. B 75, 313 (1969)Google Scholar
  45. 345.
    Olsen, H.: Flavobacterium meningosepticum. A bacteriological, epidemiological and clinical study. Thesis, Andelsbogtrykkeriet; Odense 1969Google Scholar
  46. 346.
    Olsen, H., Frederiksen, W.C., Siboni, K.E.: Flavobacterium meningosepticum in 8 non-fatal cases of postoperative bacteraemia. Lancet 1965 I, 1294Google Scholar
  47. 347.
    Olsen, H., Ravn, T.: Flavobacterium meningosepticum isolated from the genitals. Acta path, microbiol. scand. B 79, 102 (1971)Google Scholar
  48. 348.
    Owen, R.J., Lapage, S.P.: A comparison of strains of King’s group II b of Flavobacterium with Flavobacterium meningosepticum. Antonie v. Leeuwenhoek 40, 255 (1974)Google Scholar
  49. 349.
    Pedersen, M.M., Marso, E., Pickett, M.J.: Nonfermentative bacilli associated with man: III. Pathogenicity and antibiotic susceptibility. Amer. J. clin. Path. 54, 178 (1970)Google Scholar
  50. 350.
    Pelleu, G.B., Wachtel, L.W.: Dental equipment may spread microorganisms. J. environm. Health 33, 371 (1971)Google Scholar
  51. 351.
    Pickett, M.J., Manclark, C.R.: Nonfermentative bacilli associated with man: I. Nomenclature. Amer. J. clin. Path. 54, 155 (1970)Google Scholar
  52. 352.
    Pintér, M., Iványi, J.: Septicaemia due to Flavobacterium and Mima polymorpha. Brit. med. J. 1965 I, 1555Google Scholar
  53. 353.
    Plotkin, S.A., McKitrick, J.C.: Nosocomial meningitis of the newborn caused by Flavobacterium. J. Amer. med. Ass. 198, 194 (1966)Google Scholar
  54. 354.
    Polack, F.M., Locatcher-Khorazo, D., Guttierrez, E.: Bacteriologic study of donor eyes: Evaluation of antibacterial treatments prior to corneal grafting. Arch. Ophthal. 78, 219 (1967)PubMedGoogle Scholar
  55. 355.
    Reinarz, J.A., Mays, B.B., Sanford, J.P.: Antimicrob. Agents Chemother. 4, 451 (1964); zit. nach Plotkin, S.A., et al. (1966)Google Scholar
  56. 356.
    Sanchis-Bayarri Vaillant, V., Borras Salvador, R.: Estudio de dos casos de infección por “Flavobacterium meningosepticum”. Rev. clín. esp. 133, 455 (1974),Google Scholar
  57. 356a.
    Sanchis-Bayarri Vaillant, V., Borras Salvador, R.: Estudio de dos casos de infección por “Flavobacterium meningosepticum”. réf. in Microbiol. Abstr. B 10, 9106 (1975)Google Scholar
  58. 357.
    Schiff, J., Suter, L.S., Gourley, R.D., Sutliff, W.D.: Flavobacterium infection as a cause of bacterial endocarditis. Ann. intern. Med. 55, 499 (1961)PubMedGoogle Scholar
  59. 358.
    Seligman, R., Kamarov, M., Reitler, R.: Flavobacterium meningosepticum in Israel. Brit. med. J. 1963 II, 1528Google Scholar
  60. 359.
    Shibata, H., Mitsuma, T., Kato, K., Ishigaki, K., Kobayashi, T.: J. Jap. Soc. int. Med. 55, 53 (1966); zit. nach Yabuuchi, E. et al. (1970)Google Scholar
  61. 360.
    Shulman, B.H., Johnson, M.S.: A case of meningitis in a premature infant due to a proteolytic gram-negative bacillus. J. Lab. clin. Med. 29, 500 (1944)Google Scholar
  62. 361.
    Solé-Vernin, C., Ulson, C.M., Zuccolotto, M.: Verificação de Flavobacterium meningosepticum King, 1959, em São Paulo (Brasil). Rev. Inst. Med. trop. S. Paulo 2, 54 (1960)Google Scholar
  63. 362.
    Sottile, M.I., Baldwin, J.N., Weaver, R.E.: Deoxyribonucleic acid hybridization studies on Flavobacterium meningosepticum. Appl. Microbiol. 26, 535 (1973)PubMedGoogle Scholar
  64. 363.
    Stamm, W.E., Colella, J.J., Anderson, R.L., Dixon, R.E.: Indwelling arterial catheters as a source of nosocomial bacteremia. An outbreak caused by Flavobacterium species. New Engl. J. Med. 292, 1099 (1975)PubMedGoogle Scholar
  65. 364.
    Sugathadasa, A.A., Arseculeratne, S.N.: Neonatal meningitis caused by new serotype of Flavobacterium meningosepticum. Brit. med. J.1963 I, 37Google Scholar
  66. 365.
    Taplin, D., Mertz, P.M.: Flower vases in hospital as reservoirs of pathogens. Lancet 1973 II, 1279Google Scholar
  67. 366.
    Teres, D.: ICU-acquired pneumonia due to Flavobacterium meningosepticum. J. Amer. med. Ass. 228, 732 (1974)Google Scholar
  68. 367.
    Tomar, V.P.S., Sharma, O.P., Joshi, K.: Bacterial and fungal flora of normal conjunctiva. Ann. Ophthal. 3, 669 (1971)PubMedGoogle Scholar
  69. 368.
    Vandepitte, J., Beeckmans, C., Buttiaux, R.: Quatre cas des méningite à Flavobacterium chez des nouveau-nés. Ann. Soc. belge Méd. trop. 38, 563 (1958)PubMedGoogle Scholar
  70. 369.
    Vandepitte, J., Eeckels, R., Seynhaeve, V.: Infections néo-natales à propos de deux nouvelles observations congolaises. Ann. Soc. belge Méd. trop. 45, 57 (1965)PubMedGoogle Scholar
  71. 370.
    Watson, K.C., Krogh, J.G., Jones, D.T.: Neonatal meningitis caused by Flavobacterium meningosepticum type F. J. clin.Path. 19, 79 (1966)PubMedGoogle Scholar
  72. 371.
    Weeks, O.B.: Problems concerning the relationship of cytophagas and flavobacteria. J. appl. Bact. 32, 13 (1969)Google Scholar
  73. 372.
    Weeks, O.B.: Genus Flavobacterium. In: Buchanan, R.E., Gibbons, N.E. (eds.): Bergey’s Manual of Determinative Bacteriology, 8th ed. Baltimore: Williams &Wilkins 1974Google Scholar
  74. 373.
    Werthamer, S., Weiner, M.: Subacute bacterial endocarditis due to Flavobacterium meningosepticum. Amer. J. clin. Path. 57, 410 (1972)Google Scholar
  75. 374.
    Yabuuchi, E., Ohyama, A., Takeda, H., Sugiyama, M., Kono, S.: Flavobacterium meningosepticum from neonatal meningitis. Jap. J. Microbiol. 14, 241 (1970)PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1978

Authors and Affiliations

  • U. Berger
  • A.-M. Fahr
  • H. Einecke
    • 1
  1. 1.Abteilung BakteriologieHygiene-Institut der UniversitätHeidelbergDeutschland

Personalised recommendations

Cite paper

Buy options